The AEP (Australia Epilepsy Project) aims to improve the outcomes of people living with epilepsy. Through advanced testing (imaging, cognition and genetics) and through the use of Artificial Intelligence (AI) to create precision diagnosis, the AEP aims to break down treatment silos, create advanced diagnostic tools and reduce the uncertainty that characterises epilepsy care today. Up to a quarter of a million people in Australia live with epilepsy - a condition that severely impacts a person's quality of life, from health, safety and independence through to employment limitations and poor mental health outcomes. Epilepsy is the second most burdensome neurological condition after dementia and is estimated to cost $12.3 billion a year in public healthcare. Currently a five-year study, the AEP will evolve to become a health platform that will transform the delivery of health care in epilepsy, with the potential for application across other brain health conditions. A network roll out of AEP hubs has already begun and will continue across Australia to enable participants access to the best diagnostic testing, alongside at-home testing. “I want every Australian living with epilepsy to be free from seizures. This is my life’s work. The AEP team will make this a reality.” Prof. Graeme Jackson, Chief Investigator What began as a proof-of-concept pilot study, AEP received a $30Million grant from the MRFF in 2021 - the single largest government investment into epilepsy research in Australia.
